86
National Medical Care Statistics 2014
Table 9.2.1 continued: Prescribed medications by ATC levels in primary care clinics in 2014
ATC Level 1
Ý
nweighted count
Weighted count
Percent
Þ ß
prescribed medications
n
à á âã ä
552 Rate per 100
encounters 95
å
CI n
à æ çèä á é áê
Rate per 100 diagnoses
95
å
CI n
à ã
æ â ä
743
ACE inhibitors, plain 2,485
22,681 2.6
7.0 5.8–8.1 5.2 4.4–6.0
Perindopril 2,024
18,030 2.1
5.5 4.6–6.5 4.1 3.5–4.8
Beta blocking agents 1,648
14,752 1.7
4.5 3.8–5.2 3.4 2.9–3.9
Atenolol 818
7,076 0.8
2.2 1.8–2.6 1.6 1.4–1.9
Metoprolol 650
5,571 0.6
1.7 1.3–2.1 1.3 1.0–1.6
Low-ceiling diuretics, thiazides
1,010 8,836
1.0 2.7 2.1–3.3
2.0 1.6–2.5 Hydrochlorothiazide
1,008 8,819
1.0 2.7 2.1–3.3
2.0 1.6–2.4
Nervous system
áä
661 106,751
12.4 32.
á
31.1
ë
34.4 24.4 22.
á ë
26.1
Other analgesics and antipyretics
7,501 90,649
10.5 27.8 26.5–29.2
20.8 19.4–22.1 Paracetamol
7,413 89,591
10.4 27.5 26.1–28.9
20.5 19.2–21.9
Musculoskeletal system 6,733
99,136 11.5
30.4
ç á ì
ë
32.9 22.7 20.6
ë
24.
á ê
Antiinflammatory and antirheumatic products,
non-steroids 4,246
63,320 7.3
19.4 17.6–21.2 14.5 13.0–16.0
Diclofenac 1,714
24,928 2.9
7.7 6.6–8.7 5.7 4.9–6.6
Mefenamic Acid 1,291
17,775 2.1
5.5 4.8–6.1 4.1 3.5–4.6
Ibuprofen 398
5,707 0.7
1.8 1.4–2.1 1.3 1.0–1.6
Topical products for joint and muscular pain
1,101 14,241
1.7 4.4 3.7–5.0
3.3 2.8–3.7 Muscle relaxants,
centrally acting agents 603
10,648 1.2
3.3 2.6–3.9 2.4 1.9–3.0
Orphenadrine, combinations
501 9,180
1.1 2.8 2.2–3.5
2.1 1.6–2.6 Other drugs for disorders
of the musculoskeletal system
580 8,352
1.0 2.6 2.2–2.9
1.9 1.6–2.2
Antiin
ß í
ctives
ß Þ
r systemic use
5,112 76,253
á ì
á
23.4 20.7
ë
26.1 17.5 15.2
ë
19.7
Beta-lactam antibacterials, penicillins
2,057 30,007
3.5 9.2 8.2–10.2
6.9 6.0–7.7 Amoxicillin
1,100 14,729
1.7 4.5 3.9–5.1
3.4 2.9–3.9 Amoxicillin and
enzyme inhibitor 416
8,046 0.9
2.5 1.6–3.3 1.8 1.2–2.5
87
Chapter 9 : Medications
Table 9.2.1 continued: Prescribed medications by ATC levels in primary care clinics in 2014
ATC Level 1
î
nweighted count
Weighted count
Percent
ï ð
prescribed medications
n
ñ ò óô õ
552 Rate per 100
encounters 95
ö
CI n
ñ ÷ øù õ ò ú òû
Rate per 100 diagnoses
95
ö
CI n
ñ ô ÷ ó õ
743
Other beta-lactam antibacterials
1,001 16,855
2.0 5.2 4.0–6.3
3.9 3.0–4.8 Cephalexin
633 9,378
1.1 2.9 2.3–3.4
2.2 1.7–2.6 Macrolides,
lincosamides and streptogramins
921 11,940
1.4 3.7 3.2–4.2
2.7 2.3–3.1 Erythromycin
638 7,167
0.8 2.2 1.9–2.5
1.6 1.4–1.9 Quinolone
antibacterials 296
5,359 0.6
1.6 1.1–2.2 1.2 0.8–1.7
Dermatologicals 2,144
26,
ò ü
ò
3.1
ò
.3 7.3
ý
9.2 6.2 5.4
ý
6.9
Corticosteroids, plain 515
7,036 0.8
2.2 1.8–2.6 1.6 1.3–1.9
Emollients and protectives
579 6,956
0.8 2.1 1.7–2.6
1.6 1.3–1.9
Blood and blood
ð
orming organs 2,079
19,347 2.2
5.9 5.0
ý
6.9 4.4 3.
ò ý
5.1
Iron preparations 746
6,615 0.8
2.0 1.6–2.5 1.5 1.2–1.9
Antithrombotic agents 749
6,447 0.8
2.0 1.6–2.4 1.5 1.2–1.8
Acetylsalicylic acid 650
5,406 0.6
1.7 1.3–2.0 1.2 1.0–1.5
þ
itamin B12 and folic acid
505 5,244
0.6 1.6 1.2–2.0
1.2 0.9–1.5 Folic acid
450 4,479
0.5 1.4 1.0–1.8
1.0 0.8–1.3
Systemic hormonal preparations
959 16,
ú ò÷
1.9 5.0 3.6
ý
6.3 3.7 2.7
ý
4.7
Corticosteroids for systemic use, plain
823 15,079
1.7 4.6 3.3–6.0
3.5 2.4–4.5 Prednisolone
618 10,950
1.3 3.4 2.4–4.3
2.5 1.8–3.3
Sensory organs 796
ò õ
961 1.0
2
ÿ ò
2.4
ý
3.1 2.1 1.
ò ý
2.3
Antiinfectives 442
4,633 0.5
1.4 1.2–1.7 1.1 0.9–1.2
Genitourinary system and sex hormones
ô úò
5,
ü ò
ü
0.7 1.7 1.3
ý
2.2 1.3 1.0
ý
1.7 Antiparasitic
products, insecticides and repellents
235 3,
ø ü
ò
0.4 1.0 0.
ò ý
1.2
ÿ ò
0.6
ý
0.9 Various
45 609
0.1 0.2 0.1
ý
0.3 0.1 0.1
ý
0.2 Antineoplastic and
immunomodulating agents
5
ò 8
0.0 0.0 0.0
ý
0.1 0.0 0.0
ý
0.0 Total
70,711
òóô õ
552 100.0
265.4 256.7
ý
274.0
ú 8
ò ÿ
0 190.
ò ý
205.1
Note: ACE – Angiotensin converting enzyme.
